Drug patenting in 2001

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.1, 2002-01, pp. : 3-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Five years of drug patenting

By Steele P. Nelson J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 223-230

Informa Healthcare

Access to resources Recommend Favorite

Pfizer, Inc.: analysis of patenting 1998 – 2001

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 725-732

Informa Healthcare

Access to resources Recommend Favorite

Patenting transcription factors for drug discovery and therapeutics

By Manning A.M. Gonzales R. Bennett B.L.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

GlaxoSmithKline plc: analysis of patenting 1998 – 2001

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. : 1407-1415

Informa Healthcare

Access to resources Recommend Favorite

Drug safety issues in 2001

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 3-6

Adis International

Access to resources Recommend Favorite